These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9932562

  • 21. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
    Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Ziegler J, Debanne SM.
    J Adolesc Health; 2004 Dec; 35(6):434-41. PubMed ID: 15581522
    [Abstract] [Full Text] [Related]

  • 22. Trabecular bone in long-term depot-medroxyprogesterone acetate users.
    Virutamasen P, Wangsuphachart S, Reinprayoon D, Kriengsinyot R, Leepipatpaiboon S, Gua C.
    Asia Oceania J Obstet Gynaecol; 1994 Sep; 20(3):269-74. PubMed ID: 7811192
    [Abstract] [Full Text] [Related]

  • 23. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK, Sowers MR, Nichols S, Levy B.
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate.
    Modesto W, Bahamondes MV, Bahamondes L.
    J Womens Health (Larchmt); 2015 Aug; 24(8):636-40. PubMed ID: 26098552
    [Abstract] [Full Text] [Related]

  • 25. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

  • 26. Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.
    Johnson CC, Burkman RT, Gold MA, Brown RT, Harel Z, Bruner A, Stager M, Bachrach LK, Hertweck SP, Nelson AL, Nelson DA, Coupey SM, McLeod A, Bone HG.
    Contraception; 2008 Apr; 77(4):239-48. PubMed ID: 18342646
    [Abstract] [Full Text] [Related]

  • 27. The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age.
    Gai L, Zhang J, Zhang H, Gai P, Zhou L, Liu Y.
    Contraception; 2011 Mar; 83(3):218-22. PubMed ID: 21310282
    [Abstract] [Full Text] [Related]

  • 28. Changes in calcium metabolism and bone mineral density in new users of medroxyprogesterone acetate during the first year of use.
    Quintino-Moro A, Zantut-Wittmann DE, Silva Dos Santos PN, Silva CA, Bahamondes L, Fernandes A.
    Int J Gynaecol Obstet; 2019 Dec; 147(3):319-325. PubMed ID: 31479152
    [Abstract] [Full Text] [Related]

  • 29. Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study.
    Tang OS, Tang G, Yip PS, Li B.
    Contraception; 2000 Oct; 62(4):161-4. PubMed ID: 11137068
    [Abstract] [Full Text] [Related]

  • 30. Effect of depot medroxyprogesterone acetate on bone density in a Scottish industrial city.
    McGough P, Bigrigg A.
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):253-9. PubMed ID: 17763264
    [Abstract] [Full Text] [Related]

  • 31. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
    Beksinska ME, Smit JA, Kleinschmidt I, Farley TM, Mbatha F.
    Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
    [Abstract] [Full Text] [Related]

  • 32. Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception.
    Cromer BA, Lazebnik R, Rome E, Stager M, Bonny A, Ziegler J, Debanne SM.
    Am J Obstet Gynecol; 2005 Jan; 192(1):42-7. PubMed ID: 15672001
    [Abstract] [Full Text] [Related]

  • 33. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study.
    Cromer BA, Bonny AE, Stager M, Lazebnik R, Rome E, Ziegler J, Camlin-Shingler K, Secic M.
    Fertil Steril; 2008 Dec; 90(6):2060-7. PubMed ID: 18222431
    [Abstract] [Full Text] [Related]

  • 34. An exploratory study of depot-medroxyprogesterone acetate and bone mineral density in adolescent and young adult women with cerebral palsy.
    Roden RC, Noritz G, McKnight ER, Bonny AE.
    Contraception; 2020 Apr; 101(4):273-275. PubMed ID: 31935387
    [Abstract] [Full Text] [Related]

  • 35. A pilot study examining short-term changes in bone mineral density among class 3 obese users of depot-medroxyprogesterone acetate.
    Segall-Gutierrez P, Agarwal R, Ge M, Lopez C, Hernandez G, Stanczyk FZ.
    Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):199-205. PubMed ID: 23530919
    [Abstract] [Full Text] [Related]

  • 36. Bone Mineral Density and Weight Changes in Adolescents Randomized to 3 Doses of Depot Medroxyprogesterone Acetate.
    Lange HL, Manos BE, Gothard MD, Rogers LK, Bonny AE.
    J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):169-175. PubMed ID: 27789350
    [Abstract] [Full Text] [Related]

  • 37. Overview of the relationship between use of progestogen-only contraceptives and bone mineral density.
    Banks E, Berrington A, Casabonne D.
    BJOG; 2001 Dec; 108(12):1214-21. PubMed ID: 11843382
    [Abstract] [Full Text] [Related]

  • 38. [Status of bone mineral density after the long-standing application of contraception Depo-Provera].
    Zeman S, Havlík P, Zemanová J, Němec D.
    Ceska Gynekol; 2013 Jan; 78(1):116-24. PubMed ID: 23607391
    [Abstract] [Full Text] [Related]

  • 39. Depot medroxyprogesterone and bone mineral density.
    Ryan PJ, Singh SP, Guillebaud J.
    J Fam Plann Reprod Health Care; 2002 Jan; 28(1):12-5. PubMed ID: 16259808
    [Abstract] [Full Text] [Related]

  • 40. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
    Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA.
    Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.